Atlas Trials

Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy

Clinical trial NCT03603795 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03603795
Sponsor
French Innovative Leukemia Organisation
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2018-10-11
Primary completion
2022-06-15
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.